Results 11 to 20 of about 2,934 (153)
The clinical effect of an implanted vagus nerve stimulator in a patient with chronic cluster headache and focal epilepsy - A case report. [PDF]
HeadacheAbstract Background Treatment for chronic cluster headache (CCH) is often insufficient. Non‐invasive vagus nerve stimulation (nVNS) was shown to be effective as acute treatment in episodic cluster headache (ECH) and open‐label studies have shown a potential effect in CCH.
van Tilborg PJ +3 more
europepmc +2 more sources
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
British Journal of Pharmacology, Volume 180, Issue S2, Page S23-S144, October 2023., 2023 The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of approximately 1800 drug targets, and about 6000 interactions with about 3900 ligands.
Stephen P. H. Alexander +165 more
wiley +1 more source
5‐HT7 receptors mediate dilation of rat cremaster muscle arterioles in vivo
Microcirculation, Volume 30, Issue 5-6, August 2023., 2023 Abstract Objective Serotonin (5‐HT) infusion in vivo causes hypotension and a fall in total peripheral resistance. However, the vascular segment and the receptors that mediate this response remain in question. We hypothesized that 5‐HT7 receptors mediate arteriolar dilation to 5‐HT in skeletal muscle microcirculation.
William F. Jackson +4 more
wiley +1 more source
Are psychedelics the answer to chronic pain: A review of current literature
Pain Practice, Volume 23, Issue 4, Page 447-458, April 2023., 2023 Abstract Aims We aim to provide an evidence‐based overview of the use of psychedelics in chronic pain, specifically LSD and psilocybin. Content Chronic pain is a common and complex problem, with an unknown etiology. Psychedelics like lysergic acid diethylamide (LSD) and psilocybin, may play a role in the management of chronic pain.
Nina I. Kooijman +6 more
wiley +1 more source
Clinical Case Reports, Volume 10, Issue 10, October 2022., 2022 Persistent headaches sometimes concern incidental findings: A rare case of internal jugular vein agenesis. Abstract Absence of an internal jugular vein at birth is infrequent. These developmental anomalies affect approximately 0.05 percent to 0.25 percent of the population in the general community.
Mohammad Ashraful Amin +2 more
wiley +1 more source
Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review
Dermatologic Therapy, Volume 35, Issue 9, September 2022., 2022 Abstract The appearance of morphea after vaccination has been reported to date as single and deep lesions that appear exactly at the site of the skin puncture. It was therefore postulated that the origin could be the trauma related to the injection. The aim of this article is to review the various hypotheses offered in the published literature about ...
Javier Antoñanzas +5 more
wiley +1 more source
United European Gastroenterology Journal, Volume 10, Issue 5, Page 451-464, June 2022., 2022 Abstract Drug‐induced mucosal injury (DIMI) in the gastrointestinal tract is important to recognise, partly because cessation of the culprit agent alone may result in resolution of symptoms. An ever‐growing list of medications, including newer immunotherapeutic agents and targeted therapies, can cause gastrointestinal inflammation of varying severity ...
Naoimh Herlihy, Roger Feakins
wiley +1 more source
Factors associated with efficacy of occipital nerve stimulation in medically intractable chronic cluster headache. [PDF]
HeadacheAbstract Background/Objective Occipital nerve stimulation (ONS) has become an established therapy for medically intractable chronic cluster headache (MICCH), but unfortunately, one third of the patients do not respond satisfactorily. Reliable predictors of treatment success would help physicians improve indication for ONS in MICCH.
Brandt RB +7 more
europepmc +2 more sources
Headache: The Journal of Head and Face Pain, Volume 62, Issue 5, Page 624-633, May 2022., 2022 Abstract Objective To assess the long‐term efficacy and safety of erenumab in the subgroup of patients with chronic migraine (CM) in whom prior preventive treatments had failed (TF) (≥1, ≥2, and ≥3 TF medication categories) and never failed (preventive naïve or prior preventive treatments had not failed), using the data from a 52‐week, open‐label ...
Messoud Ashina +12 more
wiley +1 more source
Idiopathic red ear syndrome: A rare case report
Clinical Case Reports, Volume 10, Issue 3, March 2022., 2022 Abstract Red ear syndrome (RES) is a very rare disorder that is characterized by a unilateral or bilateral attack of paroxysmal burning sensation and reddening of the external ear. The duration of symptoms ranges from a few seconds to hours. It can occur spontaneously or be triggered by rubbing of the ear, heat or cold stimulation, brushing of hair ...
Brihaspati Sigdel, Amrit Pokhrel
wiley +1 more source